Free Trial

Revolution Medicines (RVMD) Short Interest Ratio & Short Volume

Revolution Medicines logo
$37.42 +0.24 (+0.63%)
As of 11:05 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Revolution Medicines Short Interest Data

Revolution Medicines (RVMD) has a short interest of 18.16 million shares, representing 10.62% of the float (the number of shares available for trading by the public). This marks a -1.09% decrease in short interest from the previous month. The short interest ratio (days to cover) is 9.3, indicating that it would take 9.3 days of the average trading volume of 1.67 million shares to cover all short positions.

Current Short Interest
18,160,000 shares
Previous Short Interest
18,360,000 shares
Change Vs. Previous Month
-1.09%
Dollar Volume Sold Short
$737.11 million
Short Interest Ratio
9.3 Days to Cover
Last Record Date
June 15, 2025
Outstanding Shares
186,270,000 shares
Short Percent of Float
10.62%
Today's Trading Volume
299,827 shares
Average Trading Volume
1,666,288 shares
Today's Volume Vs. Average
18%
Short Selling Revolution Medicines?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Revolution Medicines and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RVMD Short Interest Over Time

RVMD Days to Cover Over Time

RVMD Percentage of Float Shorted Over Time

Revolution Medicines Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/202518,160,000 shares $737.11 million -1.1%10.6%9.3 $40.59
5/31/202518,360,000 shares $734.03 million -2.8%11.9%10 $39.98
5/15/202518,880,000 shares $744.63 million +14.1%12.2%10.4 $39.44
4/30/202516,550,000 shares $668.29 million +0.7%N/A9.6 $40.38
4/15/202516,430,000 shares $596.74 million +1.4%10.6%10.7 $36.32
3/31/202516,200,000 shares $572.83 million -2.7%10.5%10.6 $35.36
3/15/202516,650,000 shares $651.35 million +5.1%10.8%12.6 $39.12
2/28/202515,840,000 shares $645.32 million +6.2%10.2%10.5 $40.74
2/15/202514,920,000 shares $606.80 million -6.2%9.6%9.9 $40.67
1/31/202515,910,000 shares $683.33 million -4.1%N/A10.1 $42.95
1/15/202516,590,000 shares $662.94 million +1.8%N/A10 $39.96
12/31/202416,290,000 shares $712.52 million -1.6%N/A10.4 $43.74
12/15/202416,550,000 shares $744.92 million +2.4%N/A10.7 $45.01
11/30/202416,160,000 shares $934.86 million -1.2%N/A10.6 $57.85
11/15/202416,350,000 shares $901.38 million -9.9%N/A13.7 $55.13
10/31/202418,140,000 shares $970.49 million +8.9%N/A15.9 $53.50
10/15/202416,660,000 shares $816.17 million +2.0%N/A16.3 $48.99
9/30/202416,340,000 shares $741.02 million -4.8%N/A12.9 $45.35
9/15/202417,170,000 shares $750.33 million +4.0%N/A12.5 $43.70
8/31/202416,510,000 shares $703.82 million -2.0%N/A12.1 $42.63
8/15/202416,840,000 shares $732.88 million +4.3%N/A11.5 $43.52
7/31/202416,140,000 shares $736.63 million +2.4%N/A10.7 $45.64
7/15/202415,760,000 shares $724.96 million -2.1%N/A10.4 $46.00
6/30/202416,090,000 shares $624.45 million +3.7%N/A11.8 $38.81
6/15/202415,520,000 shares $599.38 million +4.8%N/A12.4 $38.62
5/31/202414,810,000 shares $567.67 million +14.5%N/A10.6 $38.33
5/15/202412,940,000 shares $509.71 million +3.3%N/A8.7 $39.39
4/30/202412,530,000 shares $467.12 million +0.3%N/A8.5 $37.28
4/15/202412,490,000 shares $443.89 million +4.1%N/A8.7 $35.54
3/31/202412,000,000 shares $386.76 million -26.8%N/A8.9 $32.23
3/15/202416,400,000 shares $522.01 million -4.4%N/A11.5 $31.83
2/29/202417,150,000 shares $505.58 million +1.1%N/A12.2 $29.48
2/15/202416,960,000 shares $499.98 million +0.1%N/A12.8 $29.48
1/31/202416,950,000 shares $470.36 million +6.7%N/A11.9 $27.75
1/15/202415,880,000 shares $452.58 million -1.9%N/A7.8 $28.50
12/31/202316,190,000 shares $464.33 million +9.0%N/A6.5 $28.68
12/15/202314,850,000 shares $395.46 million +4.4%N/A5.7 $26.63
11/30/202314,220,000 shares $331.75 million -12.5%N/A5.7 $23.33
11/15/202316,250,000 shares $346.78 million +14.1%N/A6.7 $21.34
10/31/202314,240,000 shares $281.95 million +31.0%N/A6.1 $19.80
Banks aren’t ready for this altcoin—are you? (Ad)

Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly positioned to fill it…

Discover our #1 crypto for the market right now.
10/15/202310,870,000 shares $325.12 million -0.4%N/A5.1 $29.91
9/30/202310,910,000 shares $301.99 million -16.9%N/A8.6 $27.68
9/15/202313,130,000 shares $417.01 million +1.0%N/A12.4 $31.76
8/31/202313,000,000 shares $441.61 million +8.5%N/A12.5 $33.97
8/15/202311,980,000 shares $367.79 million +8.1%N/A11.3 $30.70
7/31/202311,080,000 shares $290.85 million -5.7%N/A10.6 $26.25
7/15/202311,750,000 shares $313.26 million -0.3%N/A13.3 $26.66
6/30/202311,780,000 shares $315.12 million +7.3%N/A12.5 $26.75
6/15/202310,980,000 shares $276.04 million +5.9%N/A11 $25.14
5/31/202310,370,000 shares $258.52 million +9.9%N/A10.4 $24.93
5/15/20239,440,000 shares $250.54 million -1.9%N/A7.7 $26.54
4/30/20239,620,000 shares $225.97 million -5.7%N/A7.8 $23.49
4/15/202310,200,000 shares $225.83 million -6.0%N/A8.2 $22.14
3/31/202310,850,000 shares $235.01 million +12.7%N/A8.4 $21.66
3/15/20239,630,000 shares $221.30 million +31.6%N/A7.8 $22.98
2/28/20237,320,000 shares $195.88 million -2.8%N/A5.9 $26.76
2/15/20237,530,000 shares $192.32 million +5.0%10.8%7.6 $25.54
1/31/20237,170,000 shares $191.73 million -10.7%10.5%7.3 $26.74
1/15/20238,030,000 shares $241.62 million -1.2%11.8%8.5 $30.09
12/30/20228,130,000 shares $193.66 million -6.2%11.9%8.6 $23.82
12/15/20228,670,000 shares $208.17 million -4.1%12.7%9.4 $24.01
11/30/20229,040,000 shares $213.25 million -6.9%13.3%9.8 $23.59
11/15/20229,710,000 shares $209.83 million -1.8%14.3%11.8 $21.61
10/31/20229,890,000 shares $200.37 million +1.0%14.6%12.1 $20.26
10/15/20229,790,000 shares $180.23 million -13.6%14.8%11.1 $18.41
9/30/202211,330,000 shares $223.43 million +13.1%17.1%11.8 $19.72
9/15/202210,020,000 shares $207.21 million +1.5%15.2%10.6 $20.68
8/31/20229,870,000 shares $205.59 million +2.1%15.1%10.7 $20.83
8/15/20229,670,000 shares $249.87 million +9.5%15.6%10.2 $25.84
7/31/20228,830,000 shares $199.47 million -18.5%15.4%9.3 $22.59
7/15/202210,840,000 shares $252.57 million -3.0%18.8%12.4 $23.30
6/30/202211,180,000 shares $217.90 million +21.4%22.4%15.3 $19.49
6/15/20229,210,000 shares $157.68 million -1.0%18.3%11.8 $17.12
5/31/20229,300,000 shares $157.91 million +9.3%18.5%13.2 $16.98
5/15/20228,510,000 shares $133.35 million +10.4%17.0%12.5 $15.67
4/30/20227,710,000 shares $153.97 million +4.5%15.5%11.8 $19.97
4/15/20227,380,000 shares $177.78 million -23.3%14.9%12 $24.09
3/31/20229,620,000 shares $245.41 million -0.6%19.4%14.9 $25.51
3/15/20229,680,000 shares $177.14 million -0.3%19.4%18.1 $18.30
2/28/20229,710,000 shares $183.71 million +7.8%19.2%19 $18.92
2/15/20229,010,000 shares $199.75 million +7.9%17.8%18.2 $22.17
1/31/20228,350,000 shares $179.69 million +9.7%15.6%17.2 $21.52
1/15/20227,610,000 shares $199.46 million -7.5%13.3%15.7 $26.21
12/31/20218,230,000 shares $207.15 million -11.2%N/A0 $25.17
12/15/20219,270,000 shares $238.52 million -3.4%16.2%20.2 $25.73
11/30/20219,600,000 shares $265.54 million -0.9%16.8%20.5 $27.66
11/15/20219,690,000 shares $307.95 million +0.8%17.0%21.4 $31.78
10/29/20219,610,000 shares $282.82 million -2.1%16.8%18.7 $29.43
10/15/20219,820,000 shares $264.65 million -4.7%17.2%18.8 $26.95
9/30/202110,300,000 shares $283.35 million +4.4%18.0%19.9 $27.51
Banks aren’t ready for this altcoin—are you? (Ad)

The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change.

Discover the protocol that crypto whales are secretly accumulating...
9/15/20219,870,000 shares $302.22 million -0.7%17.3%16.8 $30.62
8/31/20219,940,000 shares $289.15 million +2.5%17.4%16.8 $29.09
8/13/20219,700,000 shares $247.93 million -2.1%17.0%14.4 $25.56
7/30/20219,910,000 shares $283.82 million -0.2%17.4%15.8 $28.64
7/15/20219,930,000 shares $290.85 million +3.3%17.4%14 $29.29
6/30/20219,610,000 shares $305.02 million +8.3%16.8%13.3 $31.74
6/15/20218,870,000 shares $301.67 million -4.3%15.5%13.3 $34.01
5/28/20219,270,000 shares $277.27 million +5.6%16.4%14.6 $29.91
5/14/20218,780,000 shares $269.90 million +13.9%15.9%14.8 $30.74
4/30/20217,710,000 shares $269.46 million +13.9%14.0%13.2 $34.95
4/15/20216,770,000 shares $269.38 million +9.0%12.3%11.9 $39.79
3/31/20216,210,000 shares $272.81 million +6.3%11.4%10.6 $43.93
3/15/20215,840,000 shares $277.81 million +9.2%10.7%9.7 $47.57
2/26/20215,350,000 shares $241.66 million +3.1%11.2%8.9 $45.17
2/12/20215,190,000 shares $260.59 million +24.2%11.3%9.2 $50.21
1/29/20214,180,000 shares $170.54 million +5.6%8.2%7.5 $40.80
1/15/20213,960,000 shares $158.48 million No Change8.5%8.3 $40.02

RVMD Short Interest - Frequently Asked Questions

What is Revolution Medicines' current short interest?

Short interest is the volume of Revolution Medicines shares that have been sold short but have not yet been covered or closed out. As of June 15th, investors have sold 18,160,000 shares of RVMD short. 10.62% of Revolution Medicines' shares are currently sold short. Learn More on Revolution Medicines' current short interest.

What is a good short interest ratio for Revolution Medicines?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RVMD shares currently have a short interest ratio of 9.0. Learn More on Revolution Medicines's short interest ratio.

Which institutional investors are shorting Revolution Medicines?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Revolution Medicines: Jane Street Group LLC, Caption Management LLC, and Citigroup Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Revolution Medicines?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.62% of Revolution Medicines' floating shares are currently sold short.

Is Revolution Medicines' short interest increasing or decreasing?

Revolution Medicines saw a decrease in short interest in June. As of June 15th, there was short interest totaling 18,160,000 shares, a decrease of 1.1% from the previous total of 18,360,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Revolution Medicines' short interest compare to its competitors?

10.62% of Revolution Medicines' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Revolution Medicines: BioNTech SE Sponsored ADR (2.58%), Teva Pharmaceutical Industries Ltd. (3.50%), Insmed, Inc. (6.33%), Summit Therapeutics PLC (27.22%), Intra-Cellular Therapies, Inc. (2.58%), Genmab A/S Sponsored ADR (0.36%), Dr. Reddy's Laboratories Ltd (1.52%), Qiagen N.V. (2.63%), Ascendis Pharma A/S (7.33%), Moderna, Inc. (18.56%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks.

What does it mean to sell short Revolution Medicines stock?

Short selling RVMD is an investing strategy that aims to generate trading profit from Revolution Medicines as its price is falling. RVMD shares are trading up $0.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Revolution Medicines?

A short squeeze for Revolution Medicines occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RVMD, which in turn drives the price of the stock up even further.

How often is Revolution Medicines' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RVMD, twice per month. The most recent reporting period available is June, 15 2025.




This page (NASDAQ:RVMD) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners